Qingyu Zeng

4PUBLICATIONS
5CO-AUTHORS
Molecular targetsChemotherapyCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|May 06, 2026
X-Linked Inhibitor of Apoptosis Protein (XIAP) Contributes to ERK1/2-Mediated Anoikis Resistance in Hepatocellular Carcinoma.

|Apr 11, 2022
PD-L1 blockade potentiates the antitumor effects of ALA-PDT and optimizes the tumor microenvironment in cutaneous squamous cell carcinoma.

Qingyu Zeng, Jiayi Yang, Jie Ji

|Jan 23, 2022
Modified 5-aminolevulinic acid photodynamic therapy reduces pain and improves therapeutic effects in cutaneous squamous cell carcinoma mouse model.

Qingyu Zeng, Chu Zhou, Yunfeng Zhang

|Apr 16, 2021
5-Aminolaevulinic acid photodynamic therapy amplifies intense inflammatory response in the treatment of acne vulgaris via CXCL8.

Linglin Zhang, Jiayi Yang, Xiaojing Liu

Pageof 1

Frequent Collaborators

3 joint publications

Xiuli Wang

1 joint publications

Jiayi Yang

1 joint publications

Guorong Yan

1 joint publications

Guolong Zhang